GlassScriptPhysician profile
Stephanie Casey
NPI 1538780721
$1,706.19
in general payments reported to CMS, 2019-2025
15 companies · $1,512 in 2025
The $1,512 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $194 · 2025: $1,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090 · Travel and Lodging: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.52 |
| Travel and Lodging | $616.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $694.52 | 2025 | Gelpoint V-Path |
| Femselect INC. | $252.55 | 2025 | Enplace |
| Hologic Sales and Service, LLC | $212.15 | 2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Csl Behring | $158.54 | 2024 | Kcentra |
| Astellas Pharma US INC | $137.76 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $58.28 | 2025 | Myfembree |
| Ethicon US, LLC | $35.48 | 2024 | Stratafix, Ethicon, Dermabond Prineo |
| Mayne Pharma Commercial LLC | $25.62 | 2025 | |
| Coloplast Corp | $24.11 | 2025 | |
| Shield Therapeutics INC | $21.61 | 2025 | |
| Baxter Healthcare | $21.54 | 2025 | Perclot |
| Gynesonics, INC. | $18.76 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $17.58 | 2025 | |
| Meditrina | $14.22 | 2025 | |
| Abbvie INC. | $13.47 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.